Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Institution | 15.518.492 | 14,42% | US$ 630,52M | 2026-03-31 |
| OrbiMed Private Investments VI, LP | Institution | 14.809.075 | 13,76% | US$ 601,69M | 2025-05-12 |
| RA Capital Management, L.P. | Institution | 10.428.437 | 9,69% | US$ 423,71M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 7.365.038 | 6,85% | US$ 299,24M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 6.575.940 | 6,11% | US$ 267,18M | 2026-03-31 |
| BlackRock, Inc. | Institution | 6.472.991 | 6,02% | US$ 263,00M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6.395.546 | 5,94% | US$ 259,85M | 2025-03-31 |
| Janus Henderson Group plc | Institution | 5.915.556 | 5,50% | US$ 240,35M | 2026-03-31 |
| Baker Brothers Life Sciences, L.P. | Institution | 5.424.167 | 5,04% | US$ 220,38M | 2024-09-30 |
| Novo Holdings A/S | Institution | 5.350.000 | 4,97% | US$ 217,37M | 2026-04-23 |
| Driehaus Capital Management LLC | Institution | 4.477.942 | 4,16% | US$ 181,94M | 2026-03-31 |
| Artal Group S.A. | Institution | 4.430.263 | 4,12% | US$ 180,00M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 4.423.974 | 4,11% | US$ 179,75M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 4.181.497 | 3,89% | US$ 169,89M | 2025-01-27 |
| Vanguard Capital Management, LLC | Institution | 3.788.161 | 3,52% | US$ 153,91M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 3.260.000 | 3,03% | US$ 132,45M | 2026-03-31 |
| Braidwell LP | Institution | 2.347.583 | 2,18% | US$ 95,38M | 2026-03-31 |
| Morgan Stanley | Institution | 2.196.230 | 2,04% | US$ 89,23M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.789.819 | 1,66% | US$ 72,72M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 1.722.169 | 1,60% | US$ 69,97M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1.716.823 | 1,60% | US$ 69,75M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1.660.696 | 1,54% | US$ 67,47M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 1.600.000 | 1,49% | US$ 65,01M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 1.528.518 | 1,42% | US$ 62,10M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 1.449.915 | 1,35% | US$ 58,91M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1.425.845 | 1,33% | US$ 57,93M | 2026-03-31 |
| Deerfield Private Design Fund IV, L.P. | Institution | 1.301.626 | 1,21% | US$ 52,89M | 2024-09-30 |
| Bank of America Corporation | Institution | 1.267.319 | 1,18% | US$ 51,49M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1.219.717 | 1,13% | US$ 49,56M | 2026-03-31 |
| American Century Investment Management Inc | Institution | 1.147.176 | 1,07% | US$ 46,61M | 2026-03-31 |
| New Leaf Venture Partners, LLC | Institution | 1.030.161 | 0,96% | US$ 41,86M | 2025-09-30 |
| FMR LLC | Institution | 1.017.014 | 0,95% | US$ 41,32M | 2026-03-31 |
| First Light Asset Management, LLC | Institution | 1.001.846 | 0,93% | US$ 40,71M | 2026-03-31 |
| Aberdeen Group Plc | Institution | 826.059 | 0,77% | US$ 33,56M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 825.910 | 0,77% | US$ 33,56M | 2026-03-31 |
| Victory Capital Management Inc. | Institution | 789.043 | 0,73% | US$ 32,06M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 751.355 | 0,70% | US$ 30,53M | 2025-12-31 |
| Artisan Partners Limited Partnership | Institution | 659.067 | 0,61% | US$ 26,78M | 2026-03-31 |
| Marshall Wace LLP | Institution | 648.393 | 0,60% | US$ 26,34M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 596.310 | 0,55% | US$ 24,23M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
